• Scope of the Problem
• 34 min
  1. Cancer pain

  • Prof. Judith Paice
• Current Therapies
• 58 min
  2. The rational use of opioid analgesics for cancer pain - with a critique of the WHO 3-step ladder

  • Prof. Sam Ahmedzai
• 17 min
  3. Spinal analgesia for cancer pain

  • Prof. Jon Raphael
• 41 min
  4. Celiac plexus block

  • Prof. David Brown
• Future Directions
• 45 min
  5. Pain and symptom control in palliative care: new ways to think about old drugs

  • Prof. Larry Driver
• 36 min
  6. Symptom control: using technology pragmatically

  • Dr. Steven Richeimer
• From Palliative Care to Chronic Pain
• 42 min
  7. Insight and responsibility: ethics in pain medicine and palliative care

  • Prof. Rollin Gallagher
• 23 min
  8. The patient with pain: a palliative care approach

  • Dr. Janet Abrahm
• Archived Lectures *These may not cover the latest advances in the field
• 34 min
  9. Cancer pain and related symptoms: an overview

  • Prof. Judith Paice
• 74 min
  10. Cancer pain control: an evidence-based approach

  • Prof. Daniel Carr
  • Dr. Baraa Tayeb
• 47 min
  11. Optimal treatment of chronic pain

  • Prof. Gordon Irving
• 33 min
  12. Chronic cancer pain: the price of success?

  • Prof. Allen Burton

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Factors involved in the medical decision making
3. Cancer patients' symptom burden
4. Cancer pain management
5. Why treat pain?
6. Cancer pain - a significant problem
7. Pain in cancer patients
8. Causes of pain in cancer patients
9. Definitions and pathophysiology
10. Consequences of inadequately managed pain
11. Relating pain with function
12. Pain is a multidimensional experience
13. Pain perception differs among patients
14. Pain and symptom assessment
15. ABCs of pain and symptom management
16. Therapeutic approaches
17. Pharmacotherapy
18. Principles of opioid therapy
19. Commonly prescribed opioids
20. Extended-release opioids - dosages
21. Regular-release opioids - dosages
22. Rapid-onset Fentanyl for breakthrough pain/rescue
23. Methadone
24. Methadone - conversions
25. Opioid adverse effects
26. Opioid rotation
27. Managing the poorly responsive patient
28. Adjuvant analgesics/co analgesics
29. Procedural interventions
30. Nonpharmacologic treatment
31. Collateral opioid issues
32. Cancer fatigue
33. Fatigue pathophysiology
34. Symptomatic treatment of fatigue
35. Problem-specific management of fatigue
36. Corticosteroids and psychostimulants
37. Cancer anorexia-cachexia (1)
38. Cahokiain in end stage diseases
39. Starvation vs. cachexia
40. Management of anorexia-cachexia
41. Chronic nausea and vomiting
42. Opioid induced nausea
43. Nausea management
44. Problem-specific treatment
45. Anti-emetic agents
46. Acknowledgements

Topics Covered

• Medical decision making
• Cancer patients' symptom burden
• Why treat pain?
• Cancer pain: a significant problem
• Pain affects patients throughout the disease course
• Causes of pain in cancer patients
• Pain definitions and pathophysiology
• Consequences of inadequately managed pain
• Relating pain with function
• Pain and symptom assessment
• ABCs of pain and symptom assessment and management
• Therapeutic approaches
• Pharmacotherapy
• Commonly prescribed opioids
• Principles of opioid therapy for effective pain management
• NCCN guidelines for adult cancer pain
• Extended- and regular-released opioids
• Methadone
• Opioid adverse effects
• Opioid rotation
• Managing the poorly responsive patient
• Adjuvant analgesics/co-analgesics
• Procedural interventions
• Nonpharmacologic treatment
• Collateral opioid issues
• Cancer fatigue
• Treatment of fatigue
• Cancer anorexia-cachexia
• Progestational agents
• Psychotropic agents
• Anabolic agents
• Chronic nausea/vomiting
• Nausea management
• Anti-emetic agents

Links

Series:

• Cancer Pain Management

Categories:

• Cancer
• Clinical Practice
• Neuroscience
• Pharmaceutical Sciences

Therapeutic Areas:

• Neurology
• Oncology

Talk Citation

Publication History

• Published on March 22, 2009

Financial Disclosures

• Prof. Larry Driver has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.